Patients with PML display higher percentages of PD-1+ CD4+ and CD8+ T cells in the CSF and blood [54••, 55] and increased expression of PD-1 on JCV-specific CD8+ cytotoxic T-lymphocytes [55]. The gene discussed is PDCD1; the disease is progressive multifocal leukoencephalopathy.